Cart summary

You have no items in your shopping cart.

LGALS2 Antibody (Center)

Catalog Number: orb1928309

Select Product Size
SizePriceQuantity
50 μl$ 140.00
100 μl$ 240.00
50 μl Enquire
100 μl Enquire
DispatchUsually dispatched within 5-10 working days
Catalog Numberorb1928309
CategoryAntibodies
DescriptionAffinity Purified Rabbit Polyclonal Antibody (Pab)
TargetThis LGALS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 85-111 amino acids from the Central region of human LGALS2.
ClonalityPolyclonal
Species/HostRabbit
IsotypeRabbit IgG
ConjugationUnconjugated
ReactivityHuman, Mouse
Form/AppearancePurified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
UniProt IDP05162
MW14644 Da
Tested applicationsFC, IHC-P, WB
Dilution rangeWB: 1:1000, IHC-P: 1:50~100, FC: 1:10~50
Antibody TypePrimary Antibody
Clone NumberRB22637
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Alternative namesGalectin-2, Gal-2, Beta-galactoside-binding lectin
Read more...
Research AreaCell Biology
NoteFor research use only
NCBINP_006489.1
Expiration Date12 months from date of receipt.
LGALS2 Antibody (Center)

Western blot analysis of LGALS2 Antibody (Center) in mouse stomach tissue lysates (35 ug/lane). LGALS2 (arrow) was detected using the purified Pab.

LGALS2 Antibody (Center)

LGALS2 Antibody (Center) flow cytometric analysis of WiDr cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.

LGALS2 Antibody (Center)

Formalin-fixed and paraffin-embedded human colon carcinoma reacted with LGALS2 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.